<DOC>
	<DOCNO>NCT02139228</DOCNO>
	<brief_summary>Evaluate persistency immune response Haemophilus influenzae type b assess anti-PRP antibody level child vaccinate either Hib-CRM197 Hib-TT booster vaccine approximately 4 year .</brief_summary>
	<brief_title>Persistency Study After Hib-CRM ( Cross-Reacting Material ) 197 Hib-TT ( Tetanus Toxoid ) Vaccines Chinese Children</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Epiglottitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Children previously enrol V37_07E1 study receive appropriate vaccination . 2 . Children whose parent ( ) legal guardian ( ) give write consent nature study explain accord local regulatory requirement . 1 . Any confirm suspected current immunosuppressive immunodeficient condition since end V37_07E1 study , base medical history physical examination ( laboratory testing require ) . 2 . Treatment corticosteroid immunosuppressive/immunostimulant drug define : ) chronic use oral parenteral immunosuppressant ( &gt; = 15 day use ) immunemodifying drug within 60 day prior blood sampling ( short term usage topical , inhaled and/or intranasal corticosteroid allow ) ii ) receipt immunostimulants within 60 day prior Visit 1 3 . Administration immunoglobulins and/or blood product 3 month enrollment . 4 . Use investigational nonregistered product ( drug vaccine ) within 30 day precede blood sampling . 5 . Any condition , , opinion investigator , might contraindication execution blood draw .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Haemophilus influenzae type b</keyword>
	<keyword>persistency</keyword>
	<keyword>child</keyword>
	<keyword>CRM197</keyword>
	<keyword>anti-PRP antibody</keyword>
</DOC>